Contact us to find out if we have the data you need. Having offices around the globe, we are open 24 hours a day, 5 days a week with multiple language support. Please visit our Contact page to see which office is open right now!

This study provides an analysis on the total Chinese laboratory analytical instrumentation and services markets, discussing the factors driving and restraining growth, the key more…

Summary This report describes and evaluates animal biotechnology and its application in veterinary medicine and pharmaceuticals as well as improvement in food production. more…

Summary This report reviews the current state-of-art of antiviral approaches including vaccines, pharmaceuticals and innovative technologies for delivery of therapeutics. The more…

Summary Drug delivery to the cardiovascular system is different from delivery to other systems because of the anatomy and physiology of the vascular system; it supplies blood more…

Summary This report describes and evaluates cell therapy technologies and methods, which have already started to play an important role in the practice of medicine. more…

Summary Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable more…

Summary The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders. Drugs may be administered directly into the CNS or more…

Summary Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or more…

Summary Nanotechnology is the creation and utilization of materials, devices, and systems through the control of matter on the nanometer-length scale (a nanometer is one more…

Summary This report describes the role of neuroprotection in acute disorders such as stroke and injuries of the nervous system as well as in chronic diseases such as more…

Summary This report describes and evaluates the proteomic technologies that will play an important role in drug discovery, molecular diagnostics and practice of medicine in more…

Summary RNA interference (RNAi) or gene silencing involves the use of double stranded RNA (dsRNA). Once inside the cell, this material is processed into short 21-23 nucleotide more…

Summary This report deals with transdermal drug delivery - an approach used to deliver drugs through the skin for therapeutic use as an alternative to oral,intravascular, more…

Hernia repair is a standard part of general surgery, but nonetheless one that has been revolutionized by two events over the past decade and a half: the the development of more…

Genetic Technology is one of the closest-watched areas in healthcare and in the past two years Kalorama Information has published major studies on different aspects of this more…

This report specifies the importance of Stem Cell Research in Cardiology. The study is segmented by Source (Allogenic and Autogenic) and by Type (Bone Marrow Stem Cells, more…

Tissue Sealants report covers the sources of Sealants and the various applications of tissue sealants in the market. The Sources of Tissue Sealants covered include Homologous more…

This report: Provides full coverage of product segments including solid organs, experimental xenografts and artificial organs, tissue transplants, and cell transplants Detail more…

Introduction RNA therapies have been in development for a number of years, but are yet to achieve any notable commercial success. Improvements have been made following initial more…

This strategic analysis service provides a detailed analysis of the European Cancer IVD market. An in-depth analysis of marketing parameters (revenues, forecasts, geographic more…

STUDY GOALS AND OBJECTIVES Protein drugs have received enormous attention from pharmaceutical companies due to a combination of their bioreactivity, specificity, safety and more…

The Pre-clinical Stage Partnering Agreements in Biopharma report detailed understanding and analysis of how and why companies enter pre-clinical stage licensing/business more…

This research service analyses the market scenario for immunoassays in laboratory and POC setting for major seven European countries. It analyses the market trends, market more…

M&A activity in the pharma industry continues to gain momentum as a growing number of companies seek to replenish drug pipelines through biotechnology acquisitions. M&As more…

The report discusses advances in replacement organs and tissue engineering. more…

Introduction This is a critical time in U.S. history for examination of the delivery of healthcare services. Some 47 million people in the United States lack healthcare more…

This is the latest and most up-to-date Worldwide Stem Cells Market Report from Select Biosciences. This report focuses on the worldwide Regenerative Medicine/Cellular Therapy more…

This research service covers the U.S. stem cell market: current developments. Included are a disease overviews for main indications, estimated patient penetration for main more…

A critical assessment of leading companies, their research, products, partners and performance The biopharmaceutical R&D sector is taking an ever more important role in the more…

The drug delivery industry has in recent years become a key partner for pharmaceutical companies in their efforts to maximize the patent lives of successful products. Drug more…

This research services provides a current and future outlook for the evolving biosimilars market in Europe. It includes an overview of the current situation in Europe, various more…

Introduction A growing awareness is taking hold across the pharmaceutical industry: what was once impossible - tailoring treatment to specifi c groups of patients rather than more…

The prevalence of overweight and obesity is increasing at an alarming rate worldwide, driven by social and economic changes. Obesity is involved in the pathogenesis of major more…

A more in-depth understanding of the needs of scientists who are studying protein research is of growing importance as the field continues to become more complex and funding more…

This research service provides an insight into the growth opportunities for the NA and EU Biometrics markets. The research service also includes an introduction to segment more…

This research service analyzes the market for nucleic acid purification and isolation products within the United States. The market was divided into the nucleic acid more…

This research service provides detailed analysis of non-AFIS fingerprint in Notebook PC and wireless device markets . Includes revenue forecasts, market drivers, restraints, more…

The promise of profits from biosimilars grows greater, but only when a number of significant market, regulatory and clinical hurdles can be overcome. The future of the more…

Investors are turning their attention to antiviral drug discovery because there is a renewed recognition of the promising opportunities in this $20bn market. Twenty years from more…

RNA interference continues to offer significant promise for a host of therapeutic treatments. Potentially any disease-causing gene, cell type or tissue can be targeted with more…

Summary The Discovery Stage Partnering Agreements in Biopharma report provides comprehensive understanding and unprecedented access to the discovery stage partnering more…

The global outlook series on Biotechnology provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report offers a more…

A microarray is an arrangement of miniaturized test sites or "spots" on a surface. Each spot is usually no more than 250 micrometers in diameter and contains biological more…

The technologies that constitute molecular diagnostics-first-generation amplification, DNA probes, fluorescent in situ hybridization (FISH), second-generation biochips and more…

The purpose of this TriMark Publications report is to describe the specific market segment of the in vitro diagnostics market called point of care testing (POCT). It examines more…

Since its discovery, the naturally occurring RNA (ribonucleic acid) interference effect has been acclaimed as the most exciting technical breakthrough in biological research more…

In recent years, alliances between pharma and biotech companies have become common, with hundreds of relationships currently in place for drug developments across virtually more…

In 2007, the orthopedic biomaterials market was valued at over $2.6 billion, growing at an associated CAGR of 12.9% by 2014.There is great promise in the future performance of more…

The report “Asia Pacific Biotechnology Market (2008-2012)” provides an exhaustive view of the biotechnology markets in the Asia-Pacific region (Japan, China, more…

Part of Espicom's new 3-volume report on Cancer, CNS and Cardiovascular Biomarkers, this volume provides a comprehensive analysis of the cancer biomarker sector, along with a more…

By 2015, the biomarker market is forecast to be worth over US$20 billion as the cardiovascular and CNS biomarker market segments begin to mature with the launch of a number of more…

Part of Espicom's new 3-volume report on Cancer, CNS and Cardiovascular Biomarkers, this volume provides a comprehensive analysis of the cardiovascular biomarker sector, along more…

“Biomarkers have the potential to revolutionise the diagnosis of disease and the drug discovery process” Part of Espicom's new 3-volume report on Cancer, CNS and more…

Introduction The initial public offering (IPO) market for biotech and specialty pharma companies has been nearly lifeless in 2008. Investment bankers are unimpressed by the more…

Research Objectives Antibody drugs were a $24 billion business in 2007. Although most pharmaceuticals are chemically synthesized small molecules, antibodies are large and more…

Highlights This report: Determines the status of current and next generation DNA sequencing technologies and products, and assesses their worldwide growth potential over more…

Executive Summary This report aims to analyze the current and future potential of breast cancer pipeline by examining key fundamentals across the entire pipeline of drug more…

Abstract Overview Introduction Although Europe is leading the way, the biosimilar industry is very much in its infancy, with the perception of key decision makers crit more…

This strategic analysis service provides a detailed analysis of the Eastern European IVD market. An indepth analysis of marketing parameters (revenues, forecasts, geographic more…

This research service analyses the market landscape, revenue potential, market dynamics and trends in the monocloanl antibodies market focussing on five major markets in more…

Recent developments reflect the explosion in the number of kinase inhibitors that have entered clinical development in the past few years: By the end of 2006 seven kinase more…

This report: Analyzes adult and embryonic stem cell technology, applications (current and future), as well as the impact of stem cell focused products and services on more…

Introduction In the past 25 years, more than 100 recombinant proteins and MAbs have reached the global market. Biologics have scored most of their successes in the United more…

This brand new report investigates the global market for therapeutic monoclonal antibodies. While the pharmaceutical industry as a whole is suffering from single digit growth, more…

Executive Summary This report examines the emerging, fast-growing worldwide market for next-generation genome sequencing systems and services. The makers of the new sequencing more…

This is the latest most up-to-date Cancer Personalized Medicine Market Report from Select Biosciences. This report presents an up-to-date and thorough analysis of the Cancer more…

Research Objectives Antibody drugs were a $24 billion business in 2007. Although most pharmaceuticals are chemically synthesized small molecules, antibodies are large and more…

Often overshadowed by commercial interest in China and India, the countries of SE Asia offer both a growing market for biopharmaceuticals and a research-driven environment for more…

The current crisis in antibiotic R&D is attributed to an industry pipeline with few late-stage candidates capable of combating the emergence and spread of novel, more…

Aggressive adoption of cancer biomarkers will accelerate the growth of commercial markets for these products. This new report offers in-depth analysis of: The current can more…

Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. If the spread is not controlled, it can result in death. Cancer is caused by more…

The focus of this TriMark Publications report is to describe the specific segment of the life sciences market called DNA sequencing. This analysis includes all of the more…

Overview With many service models to choose from - in-house, original equipment manufacturer (OEM), multi-vendor, etc. - service providers must innovate to find new ways to more…

A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate more…

This research service outlines the key developments taking place globally and emerging trends in the field of label-free technologies for drug discovery applications. more…